Legend Biotech Corp. (LEGN)
15.99
-1.51
(-8.63%)
USD |
NASDAQ |
Nov 16, 16:00
16.10
+0.11
(+0.69%)
After-Hours: 20:00
Legend Biotech Total Assets (Quarterly) : 1.681B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.681B |
| June 30, 2026 | 1.751B |
| March 31, 2026 | 1.597B |
| December 31, 2025 | 1.734B |
| September 30, 2025 | 1.713B |
| June 30, 2025 | 1.690B |
| March 31, 2025 | 1.616B |
| December 31, 2024 | 1.670B |
| September 30, 2024 | 1.736B |
| June 30, 2024 | 1.798B |
| March 31, 2024 | 1.775B |
| December 31, 2023 | 1.849B |
| September 30, 2023 | 1.839B |
| June 30, 2023 | 1.931B |
| Date | Value |
|---|---|
| March 31, 2023 | 1.209B |
| December 31, 2022 | 1.331B |
| September 30, 2022 | |
| June 30, 2022 | 1.023B |
| March 31, 2022 | 1.044B |
| December 31, 2021 | 1.119B |
| September 30, 2021 | 813.76M |
| June 30, 2021 | 875.12M |
| March 31, 2021 | 615.27M |
| December 31, 2020 | 722.09M |
| September 30, 2020 | 708.64M |
| June 30, 2020 | 772.86M |
| March 31, 2020 | 364.94M |
| December 31, 2019 | 287.72M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 51.41B |
| Ionis Pharmaceuticals, Inc. | 2.913B |
| Cellectar Biosciences, Inc. | 29.74M |
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 408.69M |
| Shareholders Equity (Quarterly) | 1.273B |
| Debt to Equity Ratio | 0.1315 |
| Current Ratio | 3.953 |
| Net Debt Paydown Yield | 1.14% |